Nachrichten zur Genomic Health Aktie

Top-Biotech-Story nimmt Fahrt auf: AKTIONÄR-Tipp Genomic Health schießt 11 Prozent nach oben

Geduld und Mut wird belohnt: Die Aktie von Genomic Health kann im heutigen Handel satte elf Prozent zulegen, das Diagnostik-Unternehmen…

The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index

Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week…

Genomic Health Set to Join S&P SmallCap 600

NEW YORK , July 23, 2019 /PRNewswire/ -- Genomic Health Inc. (NASD: GHDX) will replace…

German Federal Joint Committee (G-BA) Issues Exclusive Nationwide Reimbursement Decision for Oncotype DX Breast Recurrence Score® Test

REDWOOD CITY, Calif. , June 20, 2019 /PRNewswire/ -- Genomic Health announced today that…

Genomic Healths Strong Growth Spooks Investors

A good start to the year and no increased guidance mean slower growth ahead....…

Heres Why Shares of Genomic Health Dropped Today

After Genomics stellar first quarter, investors are getting jittery about growth in the second half....…

Genomic Health, Inc. (GHDX) CEO Kim Popovits on Q1 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Genomic Health (GHDX) Q1 Earnings and Revenues Top Estimates

Genomic Health (GHDX) delivered earnings and revenue surprises of 17.24% and 1.58%, respectively, for the quarter ended March 2019. Do…

Genomic Health Reports First Quarter 2019 Financial Results and Recent Business Progress

REDWOOD CITY, Calif. , May 7, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results…

The Zacks Analyst Blog Highlights: ANI, Kamada, Genomic Health and NewLink

The Zacks Analyst Blog Highlights: ANI, Kamada, Genomic Health and NewLink...…

Genomic Healths New Positive Data to Boost Test Uptake

Genomic Health (GHDX) continues to see positive developments for Oncotype DX Breast Recurrence Score tests....…

Heres Why You Should Invest in Genomic Health (GHDX) Now

Having established a strong foothold in the U.S. market, Genomic Health (GHDX) is now making considerable expansion in the international…

Earnings Estimates Rising for Genomic Health (GHDX): Will It Gain-

Genomic Health (GHDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid…

Genomic Health (GHDX) Investor Presentation - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Genomic Health Continues Its Profitable Ways

The cancer test maker is growing earnings much faster than revenue....…

Erwartungen übertroffen - diese Aktie steht nun vor dem Ausbruch

Mit Spannung wurden die Zahlen des TSI-USA-Highflyers Genomic Health erwartet. Bereits in den Quartalen zuvor konnte der Konzern die Schätzungen…

The Daily Biotech Pulse: Genomic Health Earnings, AbbVies Humira Approved For Another Indication In Japan

Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week…

Genomic Health, Inc. (GHDX) Q4 2018 Earnings Conference Call Transcript

GHDX earnings call for the period ending December 31, 2018....…

Genomic Health, Inc. (GHDX) CEO Kim Popovits on Q4 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Genomic Health (GHDX) Beats Q4 Earnings and Revenue Estimates

Genomic Health (GHDX) delivered earnings and revenue surprises of 6.67% and 2.73%, respectively, for the quarter ended December 2018. Do…

Genomic Health Reports Record 2018 Fourth Quarter and Year-end Financial Results and Provides 2019 Financial Guidance

REDWOOD CITY, Calif. , Feb. 20, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today…

Genomic Health: Zahlen bergen jede Menge Sprengstoff - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Genomic Health-Aktienanalyse von "Der Aktionär": Stefan Sommer, Redakteur des Anlegermagazins "Der Aktionär", nimmt in einer aktuellen Aktienanalyse die…

Whats in the Cards for Genomic Health (GHDX) in Q4 Earnings-

Genomic Health (GHDX) is expected to gain from higher Oncotype DX breast cancer test revenues in Q4....…

Genomic Health to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call on Wednesday, February 20, 2019

REDWOOD CITY, Calif. , Feb. 13, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today…

Is Genomic Health (GHDX) Stock Outpacing Its Medical Peers This Year-

Is (GHDX) Outperforming Other Medical Stocks This Year?...…

Genomic Health (GHDX) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Genomic Health Is Positioned For Strong Returns

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is Genomic Health (GHDX) Outperforming Other Medical Stocks This Year-

Is (GHDX) Outperforming Other Medical Stocks This Year?...…

Heres Why You Should Invest in Genomic Health (GHDX) Now

Having established a strong foothold in the U.S. market, Genomic Health (GHDX) is now expanding considerably in the international arena....…

NICE Expands Recommendation for the Oncotype DX Breast Recurrence Score® Test to More Patients with Early-Stage Breast Cancer Within the United Kingdom

REDWOOD CITY, Calif. , Dec. 19, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today…

Is Genomic Health (GHDX) Stock Outpacing Its Medical Peers This Year-

Is (GHDX) Outperforming Other Medical Stocks This Year?...…

Genomic Health (GHDX), BioCartis Extend Deal to Urology

The alliance intends to develop an in vitro diagnostic (IVD) version of the Oncotype DX Genomic Prostate Score (GPS) test…

Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla Oncotype DX® Genomic Prostate Score® Test

REDWOOD CITY, Calif. and MECHELEN, Belgium , Dec. 3, 2018 …

Biocartis Group NV: Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla(TM) Oncotype DX Genomic Prostate Score® Test

Um den gesamten Artikel unter inpublic.globenewswire.com zu lesen, klicken Sie bitte auf die Überschrift...…

Genomic Health Announces Presentation of Two Large Studies at the 2018 San Antonio Breast Cancer Symposium, Reinforcing Real-world Value of the Oncotype DX Breast Recurrence Score® Test

REDWOOD CITY, Calif. , Nov. 19, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX)…

Genomic Health Starts Sprinting

Record revenue and profits lead management to increase 2018 guidance....…

Earnings Estimates Rising for Genomic Health (GHDX): Will It Gain-

Genomic Health (GHDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid…

Genomic Health (GHDX) Q3 Earnings and Revenues Top Estimates

We are encouraged by the year-over-year rise in Genomic Healths (GHDX) revenues in Q3, driven by solid performances in the…

Heres Why Genomic Health Popped as Much as 30.2% Today

The genetic-testing leader kept up its impressive streak of profitable growth during the third quarter of 2018. It now expects…

Genomic Health (GHDX) Surpasses Q3 Earnings and Revenue Estimates

Genomic Health (GHDX) delivered earnings and revenue surprises of 400.00% and 7.21%, respectively, for the quarter ended September 2018. Do…

Genomic Health, Inc. (GHDX) CEO Kim Popovits on Q3 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Genomic Health Inc (GHDX) Q3 2018 Earnings Conference Call Transcript

GHDX earnings call for the period ending September 30, 2018....…

Genomic Health Announces Record Revenue and Profit in Third Quarter 2018 Financial Results; Raises Full Year Guidance

REDWOOD CITY, Calif. , Nov. 6, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported…

Genomic Health to Announce Third Quarter 2018 Financial Results and Host Conference Call on Tuesday, November 6, 2018

REDWOOD CITY, Calif. , Oct. 30, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ:  GHDX)…

Heres Why Genomic Health, Inc. Gained 14.8% in September

The genetic testing leaders year-to-date momentum continued for yet another month. Should investors be concerned by the streaks abrupt end…

Genomic Healths Test Gets Favored by New NCCN Guidelines

Genomic Health (GHDX) forges ahead with the development of Oncotype DX Breast Recurrence Score test....…

New NCCN Breast Cancer Guidelines Elevate Oncotype DX Breast Recurrence Score® as the Only Preferred Multi-gene Test to Predict Chemotherapy Treatment

REDWOOD CITY, Calif. , Oct. 9, 2018 /PRNewswire/ -- Genomic Health, Inc.…

Heres Why You Should Invest in Genomic Health (GHDX) Now

Genomic Health (GHDX) continues to see increasing private coverage for the Oncotype DX GPS test....…

Genomic Healths New Data on Oncotype DX GPS to Boost Uptake

Genomic Health (GHDX) continues to see positive developments within the U.S. prostate cancer test business....…

New Published Data and Recent Positive Private Payor Coverage Decisions Underscore Value and Utility of the Oncotype DX Genomic Prostate Score® (GPS) Test

REDWOOD CITY, Calif. , Sept. 28, 2018 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today…